CTSI Update
The BU CTSI selected three scholars for its highly competitive KL2 Program. The BU CTSI congratulates these outstanding researchers for their efforts in developing novel solutions focused on clinical and translational research.
Tehnaz Boyle, MD-PhD
Assist. Prof., Pediatrics Emergency Medicine (BUSM)
Prehospital Teleconsultation for Pediatric Patient Safety
This project will focus on field-testing a low-cost, mobile telemedicine platform to support emergency care for children transported by ambulance.
Lawrence Were, PhD
Assist. Prof., Global Health (Sargent Gollege & BUSPH)
Health Insurance, Hospitalizations,
and Decision Making Among HIV/TB
Co-infected
Dr. Were seeks to gain expertise in “big data” evaluation of the long-term impacts of health insurance on HIV hospitalizations, costs of HIV co-infection, and insurance enrollment decision-making for HIV+ persons.
Megan Cole Brahim, PhD
Assist. Prof., Health Law, Policy, & Management (BUSPH)
Improving Quality of Care by Addressing Social Needs in Medicaid ACOs
The goal of this KL2 is to investigate if and how the quality of care may be improved by addressing Medicaid patients’ social needs in the context of Massachusetts’ transformative, statewide Medicaid ACO program.
For information about our awardees and their Mentored Career Development KL2 Projects
New Funding Opportunities
The NIH Loan Repayment Program (LRP) is now open for applications and invites qualified health professionals with doctoral degrees to apply to its 2021 application cycle. Read More

NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)


NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

National Cancer Institute (NCI)

New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)

National Institute on Drug Abuse (NIDA)

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)


Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)


Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)


Notice of Special Interest: NCCIH Administrative Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development


Notice of Change to Key Dates for PAR-18-940 “Clinical and Translational Science Award (U54 Clinical Trial Optional)”

National Center for Advancing Translational Sciences (NCATS)
Need help to prepare your NIH grant application?
Use these annotated form sets for key tips on filling out “FORMS-F”
News Highlights
Another Achievement in Administration’s Fight Against Pandemic
The EUA authorizes the distribution of COVID-19 convalescent plasma in the U.S. and its administration by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in hospitalized patients.
Cancer Grand Challenges
Cancer Grand Challenges will fund novel ideas by multidisciplinary research teams from around the world that offer the potential to advance bold cancer research and improve outcomes for people affected by cancer.

Small Business Grantees Can Make Big Impacts
Many of the companies that received funding from NIH’s Small Business Program are now harnessing their expertise and resources to respond to
COVID-19.

People with Intellectual and Developmental Disabilities Disproportionately Affected by
COVID-19
A large number of people with IDD who require
in-person care have lost the support of trained caregivers and community service providers due to the pandemic.



Are you looking for relevant articles in PubMed? LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus.
Upcoming Events
Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine

Starting September 1, the National Academies will invite public comments on a Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, part of a study commissioned by NIH and CDC. The study will recommend priorities to inform allocation of a limited initial supply of COVID-19 vaccine, taking into account factors such as racial/ethnic inequities and groups at higher risk due to health status, occupation, or living conditions. Read More
COVID-19 in Pregnancy: Clinical, Research, and Therapeutics Updates
Virtual Workshop -September 15, 2020, 10 a.m. - 4:15 p.m. ET

This workshop brings together experts in the field to discuss the progress and challenges in obstetric therapeutic research and patient care in clinical management of pregnant women and newborns with COVID-19. Read More
New Applications of Synthetic Biology to Cancer Research Challenges: 2020 Virtual Jumpstart

For researchers and clinicians at all levels of seniority with diverse expertise across the continuum of cancer research and all areas of synthetic biology and complementary fields to consider how their experience could help shape and transform the future of cancer research and biology-based technologies. Read More
Save the Date for Translational Science 2021!

Save the date for the scientific meeting that brings together trainees, junior faculty, and senior scientists, taking place March 30 – April 2, 2021, at the Washington Marriott Wardman Park. Read More
Boston University Clinical & Translational Science Institute
Accelerating Discoveries Towards Better Health 
bu.edu/ctsi | ncats.nih.gov